Reply to: Development and Validation of Nomogram Predicting Survival in Resectable Gallbladder Cancer
- 21 September 2026
- journal article
- letter
- Published by Wiley in Journal of Hepato-Biliary-Pancreatic Sciences
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Development and Validation of Nomogram Predicting Survival in Resectable Gallbladder CancerJournal of Hepato-Biliary-Pancreatic Sciences, 2026
- Neoadjuvant Chemotherapy With Gemcitabine/Cisplatin/S‐1 for Resectable Biliary Tract Cancer With FDG ‐ PET ‐Positive Lymph Node Metastasis ( KHBO1201 ): A Multicenter Phase II TrialJournal of Hepato-Biliary-Pancreatic Sciences, 2025
- Nomograms to predict individual prognosis of patients with squamous cell carcinoma of the urinary bladderBMC Cancer, 2019
- Outcome of neoadjuvant chemotherapy in “locally advanced/borderline resectable” gallbladder cancer: the need to define indicationsHPB, 2018
- THE IMPACT OF CONFOUNDER SELECTION CRITERIA ON EFFECT ESTIMATIONAmerican Journal of Epidemiology, 1989